GlassScriptPhysician profile
David James Carney
NPI 1487663134
$493.61
in general payments reported to CMS, 2019-2025
13 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.25 · 2020: $42.00 · 2022: $19.92 · 2023: $19.60 · 2024: $270 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.45 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $145.60 | 2024 | Xtandi |
| Allergan, INC. | $56.25 | 2019-2020 | |
| Bioventus LLC | $55.80 | 2024 | Exogen Ultrasound Bone Healing System |
| Tolmar, INC. | $35.85 | 2024-2025 | Eligard, Jatenzo |
| Sumitomo Pharma America, INC. | $35.48 | 2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $29.16 | 2023-2025 | Rezum Generator, Axonics |
| Laborie Medical Technologies Corp. | $26.67 | 2025 | Endosheath Technology |
| Janssen Biotech, INC. | $26.35 | 2025 | Erleada |
| Abbvie INC. | $19.92 | 2022 | |
| Smith+Nephew, INC. | $16.92 | 2024 | Stravix |
| Axonics, INC. | $16.47 | 2024 | Axonics |
| Ferring Pharmaceuticals INC. | $15.53 | 2024 | Adstiladrin |
| Stryker Corporation | $13.61 | 2025 | Blueprint Patient Specific Instrumentation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Carney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.